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Myocarditis/dilated cardiomyopathy (DCM) patients can develop autoantibodies to various cardiac antigens and one major antigen is β1-adrenergic receptor (β1AR). Previous
reports indicate that animals immunized with a β1AR fragment encompassing, 197–222
amino acids for a prolonged period can develop DCM by producing autoantibodies, but
existence of T cell epitopes, if any, were unknown. Using A/J mice that are highly susceptible to lymphocytic myocarditis, we have identified β1AR 171–190, β1AR 181–200, and
β1AR 211–230 as the major T cell epitopes that bind major histocompatibility complex
class II/IAk or IEk alleles, and by creating IAk and IEk dextramers, we demonstrate that the
CD4 T cell responses to be antigen-specific. Of note, all the three epitopes were found
also to stimulate CD8 T cells suggesting that they can act as common epitopes for both
CD4 and CD8 T cells. While, all epitopes induced only mild myocarditis, the diseaseincidence was enhanced in animals immunized with all the three peptides together as
a cocktail. Although, antigen-sensitized T cells produced mainly interleukin-17A, their
transfer into naive animals yielded no disease. But, steering for T helper 1 response
led the T cells reacting to one epitope, β1AR 181–200 to induce severe myocarditis in
naive mice. Finally, we demonstrate that all three β1AR epitopes to be unique for T cells
as none of them induced antibody responses. Conversely, animals immunized with a
non-T cell activator, β1AR 201–220, an equivalent of β1AR 197–222, had antibodies
comprising of all IgG isotypes and IgM except, IgA and IgE. Thus, identification of T cell
and B cell epitopes of β1AR may be helpful to determine β1AR-reactive autoimmune
responses in various experimental settings in A/J mice.
Keywords: autoimmunity, β1-adrenergic receptor, myocarditis, mouse model, T cells

INTRODUCTION
Myocarditis is one major cause of dilated cardiomyopathy (DCM) that can lead to heart failure in
young adults in the developed countries. Approximately, half of those affected with DCM undergo
heart transplantation due to lack of effective therapeutic options (1–4). Clinically, majority of DCM
patients (up to 80%) are designated to be idiopathic DCM (IDCM), and the detection of heart
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assumption made in these studies that a single epitope of β1AR
can act as an immunogen in various species despite the major
histocompatibility complex (MHC) alleles to be different was
found valid, identification of other potential immunodominant
epitopes, if any, was not explored. Likewise, it was unknown
whether β1AR possesses T cell epitopes and contributes to
disease. This is particularly important because, for B cells to
produce antibodies of different isotypes, T cell help is critical,
and identification of T cell epitopes may thus provide another
layer of evidence for pathologic importance of β1AR in the DCM
pathogenesis. To this end, we sought to characterize the T cell
epitopes of β1AR in A/J mice that are highly susceptible to lymphocytic myocarditis leading us to identify several epitopes that
induce differential T cell and/or antibody responses. By testing
for myocarditogenicity, we noted that the antigen-primed T cells
could induce severe myocarditis in naive recipients, but the
T cells needed to produce primarily, T helper (Th) 1 cytokines,
in addition to Th17 cytokines.

infiltrates in those affected suggests that immune dysfunction
may be an underlying mechanism in the DCM pathogenesis
(5–8). Growing evidence suggests that autoimmune responses
may be an important trigger, since DCM patients can show
autoantibodies for various antigens such as cardiac myosin,
cardiac troponin I, adenine nucleotide translocator 1 (ANT),
β1-adrenergic receptor (β1AR), and branched chain alphaketoacid dehydrogenase (BCKD) (9–12). For example, β1ARreactive antibodies can be detected in 26–60% of IDCM patients
as compared to ischemic cardiomyopathy (10–13%) or healthy
controls (<10%) (6, 7, 13). While, DCM patients can show antibody reactivity to cardiac myosin heavy chain-α (Myhc) (66%)
and troponin-I (50%), up to 80% of the end-stage IDCM patients
or more than 90% of patients using left ventricular assist device
were shown to be positive for antibodies to β1AR (6, 7). These
observations suggest that β1AR may be a major autoantigen in
the initiation and progression of DCM.
β-adrenergic receptors are classified into four subtypes with
β1AR being found primarily in the heart, whereas β2AR is
expressed in the lung, kidney, blood vessels and heart, and
β3AR-expression occurs primarily in the adipose tissue (14, 15).
Although, mRNA and protein data are lacking, existence of β4AR
has been reported, which appears to represent the low-affinity
state of β1AR (16). Belonging to G-protein-coupled receptors,
β1AR contains three each of extracellular (EC) and intracellular
loops. The natural ligands of β1AR namely, adrenaline and noradrenaline trigger activation of cyclic adenosine monophosphate
(cAMP) and protein kinase A leading to influx of calcium
(Ca2+) through L-type Ca2+ channel and cardiac contractility
(17, 18). Similar events can be expected under conditions of
autoimmunity as might occur with the presence of β1AR-reactive
autoantibodies. In fact, antibodies recognizing epitopes localized
within the EC loops, particularly EC loop II (β1AR 197–222), can
agonistically trigger Ca2+ release and cAMP activation, without
affecting interaction of β1AR with its natural ligands (6, 19). Such
antibodies have been detected in DCM patients indicating their
pathological significance (13, 20).
Experimentally, monthly immunizations for 6–18 months
with β1AR 197–222 can result in the production of antibodies
in various species such as rabbits, rats, and mice, and the immunized animals can develop features of cardiomyopathy during the
course of ~1 year with little or no myocarditis (21–25). While, an

MATERIALS AND METHODS
Mice

Six- to eight-week-old, female A/J mice (H-2a) procured from the
Jackson Laboratory (Bar Harbor, ME, USA) were maintained in
accordance with the institutional guidelines of the University of
Nebraska-Lincoln. Approval for animal studies was granted by
the Institutional Animal Care and Use Committee, University
of Nebraska-Lincoln, Lincoln, NE, USA (protocol #: 1398).
Euthanasia was performed using a carbon dioxide chamber
as recommended by the Panel on Euthanasia, the American
Veterinary Medical Association.

Peptide Synthesis

An overlapping peptide library that included a total of 46 peptides of 20-mers, except one peptide, β1AR 451–466 (16-mer)
was created. In addition to these, bovine ribonuclease (RNase) 43–56
(VNTFVHESLADVQA), biotinylated hen egg lysozyme (HEL)
46–61 (YNTDGSTDYGILQINSR) (Neopeptide, Cambridge, MA,
USA), and moth cytochrome c (MCC) 82–103 (FAGLKKANER
ADLIAYLKQATK) (GenScript, Piscataway, NJ, USA) were synt
hesized by 9-fluorenylmethyloxycarbonyl chemistry. Where indicated, acetylated β1AR (β1ARAc) that contain acetyl group at the
N-terminal end were used. All peptides were high-performance
liquid chromatography-purified (>90%), and their identities
were confirmed by mass spectroscopy. Ultrapure water was used
to dissolve peptides and stored at −20°C.

Abbreviations: DCM, dilated cardiomyopathy; β1AR, β1-adrenergic receptor;
β1ARAc, N-terminal acetylated β1-adrenergic receptor; IDCM, idiopathic dilated
cardiomyopathy; ANT, adenine nucleotide translocator 1; BCKD, branched
chain alpha-ketoacid dehydrogenase; Myhc, cardiac myosin heavy chain-α; EC,
extracellular; cAMP, cyclic adenosine monophosphate; MHC, major histocompatibility complex; Th, T helper; RNase, bovine ribonuclease; HEL, hen egg lysozyme;
MCC, moth cytochrome c; CFA, complete Freund’s adjuvant; PT, pertussis toxin;
H&E, hematoxylin and eosin; IHC, immunohistochemistry; Abs, antibodies; RT,
room temperature; HRP, horseradish peroxidase; LV, left ventricle; LVID, left
ventricular internal diameter; RWT, relative wall thickness; BSA, body surface area;
3
[H]-thymidine, tritiated-thymidine; cpm, counts per minute; SA, streptavidin;
DELFIA, dissociation-enhanced lanthanide fluoroimmunoassay; LNCs, lymph
node cells; 7-AAD, 7-aminoactinomycin-D; dext+, dextramer+; IL, interleukin;
IFN, interferon; TNF, tumor necrosis factor; LPS, lipopolysaccharide; MNCs,
mononuclear cells; T. cruzi, Trypanosoma cruzi.
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Immunization Procedures

Peptide emulsions were prepared in complete Freund’s adjuvant
(CFA) containing Mycobacterium tuberculosis H37RA extract
(Difco Laboratories, Detroit, MI, USA) to a final concentration
of 5 mg/ml. To induce disease, animals were immunized twice
s.c., in inguinal and sternal regions on days 0 and 7, and all animals received pertussis toxin (PT, List Biological Laboratories,
Campbell, CA, USA; 100 ng/mouse) i.p., on days 0 and 2 after
the first immunization (26–29). In pooled settings, 50 µg of each
peptide was used, and when peptides were used individually,
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100 µg was used per animal. To measure T cell responses in some
experiments, a single dose of peptide emulsions were used.

and images were captured in the short-axis view at the mid-left
ventricle (LV) level, verified by the presence of prominent papillary muscles. Three consecutive cardiac cycles, defined from
the peak of one R wave to the peak of the following R wave
were measured and used for analysis as previously reported
(30). In brief, linear measurements were performed using the
M-mode view to assess width of the intraventricular septum
at diastole and the internal diameter of the LV at diastole and
systole. The Teichholz formula {LV volume = [7/2.4 + left
ventricular internal diameter (LVID)] × LVID3} was used to
calculate end-diastolic and end-systolic volumes (30). The
relative wall thickness (RWT) was calculated as the ratio of
2 × LV posterior wall thickness and LV internal diameter at
end-diastole. The RWT normal range is between 0.32 and 0.42.
Total body surface area (BSA) was calculated using the Meeh’s
formula (BSA = 10 × [weight]2/3) (32). All measurements were
indexed to BSA to account variation in size.

Histology

Hearts, and non-cardiac tissues (brain, lung, liver, and kidney)
collected at termination on day 21 postimmunization were fixed
by immersing in 10% phosphate-buffered formalin (26, 28).
Longitudinal tissue layers were cut from hearts, and also from
non-cardiac tissues. Serial sections with 5 µm thickness were
then obtained and stained with hematoxylin and eosin (H&E).
Analysis was performed by a board-certified pathologist blinded
to treatment. After ascertaining the inflammatory changes, total
number of inflammatory foci were determined by sections with
the largest number of foci or by adding non-overlapping foci
across sections as reported previously (26, 28, 30, 31).

Immunohistochemistry (IHC)

To detect T cells in hearts, formalin-fixed paraffin-embedded
tissue sections were stained with rabbit anti-mouse CD3 (clone
SP7, 1:100, Abcam, Cambridge, MA, USA), rabbit anti-mouse
CD4 (polyclonal, 1:100, Novus Biologicals, Littleton, CO, USA),
and rabbit anti-mouse CD8 (clone EP1150Y, 1:100, Novus
Biologicals) or their isotype controls. For non-T cells namely,
neutrophils, macrophages, and B cells, rat anti-mouse Ly6G
(clone 1A8, 1:250, Leinco Technologies, Fenton, MO, USA),
rabbit anti-mouse CD11b (clone EPR1344, 1:3,500, Abcam)
(30), and rat anti-mouse CD19 (clone 6OMP31, 1:1000, Thermo
Fisher Scientific, San Diego, CA, USA) and their isotype controls were used, respectively. In brief, after deparaffinization,
rehydration, and blockade of endogenous peroxidase activity,
antigen retrieval was performed by treating the sections with
10 mM sodium citrate buffer (pH 6.0) in a water bath at 98°C
for 15–40 min or using a pressure cooker. Sections were then
blocked with 5% non-fat dry milk for 30 minutes, incubated with
primary antibodies (Abs) at 4°C overnight; followed by incubation with horseradish peroxidase (HRP)-conjugated, goat antirabbit IgG or goat anti-rat IgG (Abcam) as secondary antibodies
for 2 h at room temperature (RT). Diaminobenzoic acid was
used as a substrate for color development before counterstaining with hematoxylin (26, 30). For quantitative analysis (T cells:
CD3+, CD4+, and CD8+; and non-T cells: Ly6G+, CD11b+, and
CD19+) in the heart, five random areas were selected from the
representative sections and nuclear staining was confirmed using
nuclear V9 software (Aperio Technologies, Vista, CA, USA). Cells
positive for each marker were then enumerated and normalized
to 1 mm2 area using Aperio ImageScope Analysis Software (Leica
Biosystems, MN, USA) as we have described previously (30).

T Cell Proliferation Assay

At termination, lymph nodes (maxillary, mandibular, axillary,
inguinal, and popliteal) and spleens were harvested from
immunized animals to prepare single cell suspensions. Similarly,
splenocytes were prepared from naive animals. After lysing the
erythrocytes and washing, cell pellets were suspended in RPMI
medium containing 10% fetal bovine serum, 1 mM sodium pyruvate, 4 mM l-glutamine, 1 × each of non-essential amino acids
and vitamin mixture, and 100 U/ml penicillin–streptomycin
(Lonza, Walkersville, MD, USA; hereafter called growth
medium). In some experiments, CD4 T cells and CD8 T cells
were enriched to a purity of ~95% by negative selection based
on magnetic separation using IMAG (BD Biosciences, San Jose,
CA, USA) (31). To stimulate CD4 and CD8 T cells, syngeneic
naive irradiated splenocytes loaded with peptides were used as
antigen-presenting cells at a ratio of 1:1. Cells were stimulated
at a density of ~5 × 106 cells/ml in triplicates with or without the
immunizing peptides (0–100 µg/ml) in growth medium. RNase
43–56 or HEL 46–61 were used as irrelevant controls. After 2 days,
cells were pulsed with tritiated 3[H]-thymidine (1 μCi/well; MP
Biomedicals, Santa Ana, CA, USA), and 16 h later, proliferative
responses were measured as counts per minute (cpm) using a
Wallac liquid scintillation counter (Perkin Elmer, Waltham, MA,
USA) (26, 28, 30).

MHC Class II-Binding Assay

A/J mice express two MHC class II alleles, IAk and IEk (33, 34),
and to determine the affinities of β1AR peptides, soluble
IAk and IEk monomers were expressed (34, 35). In brief, the
β-chain in each of IAk and IEk constructs contain sequence
for class II-associated invariant-chain peptide 88–102
(VSQMRMATPLLMRPM) linked with thrombin cleavage
site (34, 35). After expressing in the baculovirus, soluble IAk
and IEk monomers were treated with thrombin (20 U/mg;
Novagen, Madison, WI, USA) to release class II-associated
invariant-chain peptide leading us to obtain empty IAk and
IEk molecules. Reaction mixtures were prepared to include
empty IAk or IEk monomers (0.35 µg), competitor peptides
(β1ARAc 171–190, β1ARAc 181–200, β1ARAc 201–220, and β1ARAc

Echocardiography and Image Analysis

Transthoracic echocardiography was performed in anesthetized animals immunized with or without a cocktail of β1ARAc
171–190, β1ARAc 181–200, and β1ARAc 211–230 on day 20.
Scanning was performed by a research sonographer, blinded
to the study groups, using a commercially available echocardiography system (Vivid 7, General Electric, Wauwatosa, WI,
USA) with an M12-L linear array transducer as we reported
previously (30). The mice were anesthetized with isoflurane

Frontiers in Immunology | www.frontiersin.org
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Cytokine Secretion

211–230) (0.00001–100 µM), and constant amounts of the
biotinylated reference peptides HEL 46–61 (for IAk) or MCC
82–103 (for IEk) (1 µM) in a buffer containing 50 mM sodium
phosphate pH 7.0, 100 mM sodium chloride, 1 mM EDTA,
and 1 × protease inhibitor (Sigma-Aldrich, St. Louis, MO,
USA) (36–38). After incubating overnight at RT, the mixtures
were transferred to 96-well white fluorescence plates coated
with anti-IAk (clone 10-2.16, BioXcell, West Lebanon, NH,
USA), and anti-IEk (clone M5/114, BioXcell) Abs (10 µg/ml)
in 0.2 M sodium phosphate buffer, pH 6.8, blocked with 2%
bovine casein; and the plates were incubated on a rocker at
RT for 1 h. Finally, after adding 100 µl of europium-labeled
streptavidin (0.1 µg/ml) and dissociation-enhanced lanthanide
fluoroimmunoassay (DELFIA) enhancement solution (Perkin
Elmer) sequentially, fluorescence intensities were measured at
excitation/emission wavelengths of 340/615 nm using a Victor
Multilabel Plate Reader (Perkin Elmer). The IC50 values were
determined based on the concentrations of competitor peptides
needed to prevent 50% binding of the reference peptides as we
have described previously (26, 28, 30).

Supernatants were obtained from lymph node cell (LNC) cultures
prepared from immunized animals that were stimulated with
or without acetylated or non-acetylated, β1AR 171–190, β1AR
181–200, and β1AR 211–230 and RNase 43–56/HEL 46–61
(controls) (50–100 µg/ml) on day 3 poststimulations. Cytokine
analysis was performed using beads conjugated with capture
and detection Abs with the standard curves being derived from
serial dilutions of mouse cytokine standard mixtures, consisting
of IL-2, interferon (IFN)-γ, IL-4, IL-6, IL-10, IL-17A, and tumor
necrosis factor (TNF)-α as recommended by the manufacturer’s
guidelines (BD Biosciences). Briefly, capture bead/cytokine
antibody conjugates were first prepared, and the mixtures were
added to a tube containing diluted standards or test samples,
followed by addition of detection antibodies. After acquiring by
flow cytometry, FCAP Array Software was used to analyze the
data (BD Biosciences) (26, 30).

Induction of Myocarditis by Adoptive
Transfer of Antigen-Sensitized T Cells

Lymph node cells obtained from animals immunized with
individual peptides, β1ARAc 171–190, β1ARAc 181–200, or β1ARAc
211–230 on day 21 postimmunizations were stimulated with the
corresponding immunizing peptides (20 µg/ml) for 2 days followed by resting in IL-2 medium. In a separate set of experiments,
animals were immunized with a mixture of β1ARAc 171–190,
181–200, and 211–230 peptides and their lymphocytes were
stimulated with the immunizing peptides individually (50 µg/
ml) for 2 days and then IL-2 medium was added. On day 3, one
of the two aliquots of cells were exposed to a mixture of Th1- and
Th17-polarizing conditions by adding recombinant mouse IL-12
(20 ng/ml), IL-1β (30 ng/ml), IL-6 (30 ng/ml), IL-23 (50 ng/ml)
(all cytokines were procured from BioLegend, San Diego, CA,
USA), and human transforming growth factor-β1 (10 ng/ml;
eBioscience, San Diego, CA, USA) as reported previously (41–44),
and the other was maintained in IL-2 medium alone. Flow cytometrically, we analyzed the percentages of cytokine-producing
cells on days 3 and 6 following polarization as we have described
previously (28, 31, 40). Viable cells harvested on days 8–10 were
administered through i.p., or retro-orbital sinus (4–14 × 106 cells/
animal) into naive mice primed with lipopolysaccharide (LPS,
25 µg/mouse i.p., day −4 and day 0). PT was administered i.p.,
(100 ng/mouse) on days 0 and 2 posttransfer (26, 30, 45). Saline
recipients and the LPS/PT-primed naive mice were used as controls. Animals were euthanized on 14–21 days after transfer to
collect hearts for histology.

Creation of MHC Class II/IAk
or IEk Dextramers to Determine
Antigen-Specificity of T Cells

To enumerate the frequencies of antigen-specific CD4 T cells, we
created IAk dextramers for β1AR 171-190 and β1AR 211–230, and
IEk dextramers for β1AR 181–200. To create IAk dextramers, the
nucleotide sequence for β1AR 171–190 (acgcgcgcgcgagcgcgggccctcgtgtgcacagtgtgggccatctcggcgttggtgtcc) and β1AR 211–230
(aacgaccccaagtgctgcgatttcgtcaccaacagggcctacgccatcgcctcgtccgtc)
was inserted into the IAk-β construct that we had described
previously (35, 39), whereas IAk/RNase 43–56 (control) dextramers were readily available in our laboratory (30, 35, 40). The
soluble, IAk/β1AR 171–190 and IAk/β1AR 211–230 molecules
were expressed in sf9 cells using baculovirus expression system.
After purifying through anti-IAk-affinity column, the IAk/β1AR
171–190 and IAk/β1AR 211–230 monomers were biotinylated and
dextramers were derived using streptavidin (SA)/fluorophoreconjugated dextran molecules as described previously (35, 39).
IEk/β1AR 181–200 and IEk/MCC 82–103 (control) dextramers
were prepared based on peptide-exchange reaction as we have
described previously (34).
To stain with dextramers, lymphocytes obtained from lymph
nodes and spleens from immunized animals were stimulated
with the immunizing peptides namely, β1ARAc 171–190, β1ARAc
181–200, and β1ARAc 211–230 (20 µg/ml) for 2 days and growth
medium containing interleukin (IL)-2 (IL-2 medium) was then
added. After harvesting viable cells by ficoll density-gradient centrifugation on day 5, cells were rested in the IL-2 medium. During
7–10 days poststimulation, cells were stained with IAk-[β1ARAc
171–190 (37°C) or β1ARAc 211–230 (RT), and RNase 43–56,
control] or IEk-dextramers [β1ARAc 181–200 (RT) and MCC
82–103, control] followed by anti-CD4 and 7-aminoactinomycinD (7-AAD). After washing, and acquisition by flow cytometry,
percent dextramer+ (dext+) cells were analyzed within the live
cells (7-AAD−) using Flow Jo software (34, 35, 39).

Frontiers in Immunology | www.frontiersin.org

Detection of Antibodies That React
with β1ARAc Peptides

ELISA was used to measure antibodies that react with β1ARAc
peptides in the serum samples collected from immunized
animals at termination on day 21 as described previously (26).
Microtiter polystyrene plates were coated with or without β1ARAc
171–190, β1ARAc 181–200, β1ARAc 191–210, β1ARAc 201–220, and
β1ARAc 211–230 or irrelevant control (RNase 43–56) (10 µg/ml)
in 1 × coating buffer (eBioscience) and the plates were incubated
4
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at 4°C overnight. After washing/blocking, serum samples (1:100)
were added in duplicates, and the plates were incubated at 37°C
for 1 h followed by addition of HRP-labeled goat anti-mouse
immunoglobulins (Igs), IgG1, IgG2a, IgG2b, IgG3, IgM, IgA,
and IgE (Southern Biotech, Birmingham, AL, USA) as secondary
antibodies. Two hours after incubation at RT, 1 × tetramethylbenzidine solution was added as a substrate (eBioscience), and
reactions were stopped using 1 M phosphoric acid. The plates
were read at 405 nm using an automated ELISA reader (BioTek
instruments, Winooski, VT, USA) to measure OD values (26, 46).

myocarditis-inducing protocol by administering peptide emulsions twice with a week interval as we and others have reported
for various cardiac antigens (26, 28, 49). These analyses revealed
detection of myocarditis in animals that received peptides from
pools namely, IV, VII, VIII, and IX, with a disease incidence of
20–40% and the inflammatory foci were in the range of 2–42
(Table S3 in Supplementary Material). However, by evaluating
T cell responses using RNase 43–56 as an irrelevant control,
a trend was noted in that animals receiving a pool of peptides
starting from β1AR 171–190 to β1AR 211–230 (pool IV) had good
T cell responses up to ~2- to 5-fold that also had diffused inflammatory foci in one animal (Table S3 in Supplementary Material).
Similar pattern was noted for one other group (pool VII)
with the proliferative responses noted up to two-fold for three
peptides (β1AR 321–340, β1AR 351–370, and β1AR 361–380),
whereas T cell responses were not significant in the peptide pools,
VIII and IX (Table S3 in Supplementary Material). Likewise,
significant T cell responses although noted for few peptides in
pools, I, II, III, V, and VI, inflammation was absent in the hearts of
immunized animals (Table S3 in Supplementary Material). These
observations suggest that occurrence of myocarditis might not be
due to T cell responses in all the pools.
Since, our intent was to identify T cell epitopes which are capable to induce myocarditis, and the peptides spanning a stretch
of 60 aa (β1AR 171–230, pool IV; Table S3 in Supplementary
Material) that also encompasses β1AR 197–222 which was previously reported to be a B cell epitope (13, 48), we focused on all the
five peptides from pool IV (Table S4 in Supplementary Material).
For comparative analysis, we also randomly chose two other peptides from pool VIII namely; β1AR 381–400 and β1AR 391–410
that did not show T cell responses, but showed myocarditis (Table
S3 in Supplementary Material). In the individual immunization
settings, the disease incidence was noted to be 20–40%, but
unexpectedly, none of the animals had significant disease, except
two peptides that induced mild disease (β1AR 181–200 and β1AR
211–230) (Table S4 in Supplementary Material).
We and others had previously reported that the peptides
modified to include acetyl group at N-terminal end can induce
significant myocarditis such as Myhc 614–643 in Balb/c mice
(26, 29). It has been proposed that acetylated peptides can be
prevented from intracellular degradation leading to their stable
binding to MHC molecules (29, 50). Thus, we decided to use
the acetylated peptides, and focused only the peptides that were
located within the stretch of β1AR 171–230 (Table 1). While, some
enhancement was noted with the ability of acetylated peptides
(β1ARAc 171–190 and β1ARAc 181–200) to induce myocarditis,
only 25% of animals had the disease (Table 1). Expectedly, hearts
from control groups (naive and CFA/PT) were negative for
inflammatory changes. The T cell responses however were consistently noted for β1ARAc 171–190, β1ARAc 181–200, and β1ARAc
211–230 (Figure 1), whereas β1ARAc 191–210 and β1ARAc 201–220
remained as non-T cell activators (Figure S1A in Supplementary
Material). The proliferative responses noted in the immunized
animals were dose-dependent, and also specific to antigen, since
responses to control antigen (RNase 43–56/HEL 46–61) were
lacking (Figure 1). We then asked whether T cells primed with
a pool of all three peptides that showed T cell responses (β1ARAc

Statistics

Kruskal–Wallis test was used to compare differences in cytokine
production, inflammatory foci and antibodies where more than
two groups were involved. When significant differences were
noted (P < 0.05), analyses were continued with post hoc tests via
Dunn–Sidak multiple test correction. Differences in the incidence
of myocarditis between groups were compared using the Fisher’s
exact test. Student’s t-test was used to determine differences in
the T cell proliferative responses, echocardiography parameters,
MHC-binding affinities, frequencies of dext+ cells, and cytokine
producing cells.

RESULTS AND DISCUSSION
In this report, we describe identification of T cell epitopes of
β1AR in A/J mice that are highly susceptible to lymphocytic myo
carditis induced by various cardiac antigens namely, Myhc (28),
cardiac troponin I (47), ANT (26), and BCKD kinase (30). Impor
tance of β1AR in the cardiac disease has long been investigated in
that patients with myocarditis/DCM, in particular, IDCM show
β1AR-reactive antibodies. Such a reactivity has been proposed
to signify a marker of disease-progression and/or to predict
prognosis (6, 20). β1AR-reactive antibodies localized to EC loop
II particularly for β1AR 197–222 was also helpful to screen DCM
patients in clinical settings (13, 48). Because the sequence of β1AR
197–222 is found conserved with 100% identity between humans,
mice and rats, and 96.1% with rabbits (Table S1 in Supplementary
Material), perhaps, rodent studies were undertaken to determine
the pathogenic significance of β1AR 197–222 in the development
of myocardial disease. Expectedly, rats and rabbits immunized
with β1AR 197–222 developed cardiac dysfunctions suggestive
of DCM, with minimal or no heart infiltrates (21–25). But all
these disease-inducing protocols required biweekly or monthly
immunizations for a period of 6–18 months. In addition, animals
immunized with β1AR had agonistic antibodies of IgG isotype
that trigger cardiac arrhythmias by activating cAMP/protein
kinase A pathway and apoptosis of cardiomyocytes (19). In these
conditions, however, relevance of β1AR-reactive T cell responses
in the causation of cardiac autoimmunity remained uninvestigated. Thus, we made efforts to identify T cell epitopes of β1AR
and their ability to induce myocarditis in A/J mice.
To identify T cell epitopes, we created an overlapping peptide
library that included 46 peptides of 20-mers spanning the entire
length of mouse β1AR (466 amino acids; Table S2 in Supplementary
Material). For initial screening, we made nine pools with four to
five peptides in each, and immunized A/J mice using the standard
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171–190, β1ARAc 181–200, and β1ARAc 211–230) can collectively
contribute to myocarditis-induction. These experiments led us to
note a significant increase in the disease incidence (63%), but the
disease-severity remained unaltered (Table 1, P = 0.03).
Histologically, in contrast to normal heart sections, inflammatory foci consisting of mononuclear cells (MNCs) involving
pericardium, myocardium and endocardium were detected in
animals immunized with β1ARAc 171–190, β1ARAc 181–200, or
β1ARAc 211–230 individually or as a mixture, but necrosis or
fibrosis were absent (Figure 2A). Consistent with these observations, echocardiographic analysis also revealed mild cardiac
abnormalities as indicated by trends with increased heart rate
relative to control animals (384.0 ± 10.10 vs. 337.67 ± 20.98
beats/min; P = 0.08, Table S5 in Supplementary Material).
Immunized animals showed decreased LVID index at end-systole
(0.26 ± 0.01 vs. 0.33 ± 0.01 mm; P = 0.047) and end-systolic
volume (17.50 ± 2.89 vs. 33.33 ± 8.33 µl; P = 0.09, Table S5 in
Supplementary Material) associated with an increase in left
ventricular systolic function reported as ejection fraction and
fractional shortening. The immunized mice showed the absence
of hypertrophy and dilation as indicated by the lack of significant
increase in the diastolic septal/posterior wall thickness indices
and end-diastolic volume. However, the RWT of 0.43 in the
immunized mice (normal RWT = 0.32–0.42) identifies concentric
remodeling without hypertrophy whereas RWT of 0.39 identifies a
normal morphology as seen in the naive mice (51). No differences

with body weight (19.20 ± 0.32 vs. 18.23 ± 0.44 g), heart weight
(87.25 ± 1.11 vs. 84.00 ± 1.73 mg) or heart/body weight ratio
(4.55 ± 0.03 vs. 4.61 ± 0.07 mg/g) were observed between immunized and control groups (Figure S2 in Supplementary Material).
Previous reports indicate that rats immunized with β1AR 197–222
for a prolonged period showed early cardiomyopathic changes at
1 year, but with no necrosis or fibrosis including changes in heart
to body weight ratios (21). Likewise, cardiac abnormalities could
be detected in Balb/c mice only at 25 weeks but not at 14 weeks
postimmunization (22). These observations support the notion
that β1AR-induced cardiomyopathy may be a slow progressive
disease.
Nonetheless, we further characterized the immune cells by
IHC and the analysis revealed that heart sections from animals
immunized with a mixture of three peptides as indicated above
had CD3+ (136 ± 9 cells/mm2), CD4+ (92 ± 1 cells/mm2), CD8+
(66 ± 21 cells/mm2) T cells, and CD11b+ (65 ± 13 cells/mm2)
macrophages, whereas Ly6G+ neutrophils, and CD19+ B cells
were absent (Figure 2B: bottom panel). Expectedly, sections
from control groups were negative for all the markers tested
except rare CD11b+ cells. While, detection of T cells, mainly
CD4 T cells and macrophages suggest the features of delayed-type
hypersensitivity (DTH) reaction as noted with other myocarditis
models (26, 28–30), detection of CD8 T cells was not expected
although they can form a component of DTH reaction. This
led us to test a possibility that both CD4 and CD8 T cells may
have a role in myocarditis-induction. We sorted both subsets of
T cells by magnetic separation from animals immunized with
β1ARAc 171–190, β1ARAc 181–200, or β1ARAc 211–230 to a purity
of ~95% (Figure S3A in Supplementary Material), and tested their
ability to respond to antigens in a proliferation assay. As shown
in Figure S3B in Supplementary Material, both CD4 and CD8
T cells responded to the corresponding immunizing peptides
dose-dependently, and also antigen-specifically, since responses
to HEL 46–61 were lacking. While, these data suggest that the
disease induced with β1ARAc 171–190, β1ARAc 181–200, and
β1ARAc 211–230 might have involved the mediation of both CD4
and CD8 T cells, existence of three CD8 T cell epitopes in as many
CD4 T cell epitopes for a single autoantigen is unusual. But, we
and others have previously reported that CD4 T cell epitopes of

TABLE 1 | Induction of myocarditis by β1ARAc peptides.
Groups

Incidence (%) Inflammatory focia

Naive
CFA/PT
β1ARAc 171–190
β1ARAc 181–200
β1ARAc 191–210
β1ARAc 201–220
β1ARAc 211–230
β1ARAc 171–190, 181–200, and 211–230

0/6 (0)
0/6 (0)
3/12 (25)
3/12 (25)
0/5 (0)
1/5 (20)
2/12 (17)
5/8 (63)*

0
0
2.7 ± 1.2
3.7 ± 1.8
0
13
1.0 ± 0.0
2.8 ± 1.1

a
Represents mean ± SEM values derived from myocarditic animals.
*P < 0.05 vs. controls.

FIGURE 1 | T cell responses induced by β1ARAc peptides. Lymph node cells (LNCs) obtained from animals immunized with β1ARAc 171–190, β1ARAc 181–200, and
β1ARAc 211–230 were restimulated with or without the corresponding peptides and RNase 43–56/HEL 46–61 (negative control) for 2 days. After pulsing with
3
[H]-thymidine for 16 h, proliferative responses were measured as cpm. Mean ± SEM values derived from three to four individual experiments, each involving three
to eight mice are shown. *P < 0.05 and **P < 0.01 vs. negative controls.
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FIGURE 2 | Histological evaluation of hearts from animals immunized with β1ARAc peptides. (A) Hematoxylin and eosin (H&E) staining. Groups of mice were
immunized with or without indicated peptides in complete Freund’s adjuvant (CFA) twice with an interval of 7 days. At termination on day 21, hearts were collected
to determine inflammatory changes by H&E staining analysis. Mild myocarditis as indicated by infiltrates containing mononuclear cells (MNCs) were noted in all
groups. Boxed areas are shown at higher magnifications to the right in each panel. Arrows, inflammatory foci. Scale bar: 120 µm (overview images, 10×), 30 µm
(magnifications, 40×). (B) Immunohistochemistry. Heart sections obtained from animals immunized with a mixture of β1ARAc 171–190, 181–200, and 211–230 were
evaluated for the presence of T cells (CD3, CD4, and CD8) and non-T cells (Ly6G+ neutrophils, CD11b+ macrophages and CD19+ B cells) using antibodies for each
marker or their isotype controls. After washing and addition of horseradish peroxidase (HRP)-conjugated secondary antibodies, cells positive for each marker were
identified as shown with arrows. Representative sections from groups involving five to eight mice are shown. Naive and CFA/PT, controls; and scale bar, 60 µm.
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by flow cytometry (Figure 4). As we have reported previously
for various self- and foreign-antigens (28, 34, 35, 54), we noted
that the dextramers for all the three T cell epitopes of β1AR were
also preferentially found to bind activated CD4high than CD4low
subset. The percent dext+ CD4high T cells were: β1ARAc 171–190
(3.27 ± 0.56%) vs. RNase 43–56 (0.52 ± 0.08%) (P = 0.049,
Figure 4A), β1ARAc 181–200 (0.71 ± 0.09%) vs. MCC 82–103
(0.33 ± 0.03%) (P = 0.028, Figure 4B), and β1ARAc 211–230
(0.51 ± 0.01%) vs. RNase 43–56 (0.12 ± 0.01%) (P = 0.0003,
Figure 4C). The data point to a possibility that the antigensensitized CD4 T cells might be the mediators of disease.
Next, we sought to determine the pathogenic potential of
T cells sensitized with β1AR 171–190, β1AR 181–200, or β1AR
211–230 by analyzing their ability to produce various inflammatory cytokines (Figure 5). Supernatants from cultures stimulated
with or without specific or control (RNase 43–56/HEL 46–61)
antigens revealed the presence of all cytokines, except IL-4. Data
revealed no striking differences for any of the cytokines except
that IL-17A was tended to be elevated in β1AR 171–190 and β1AR
181–200 cultures (P = 0.06, Figure 5). Conversely, production of
IFN-γ, another key cytokine was not altered including other proinflammatory (IL-6 and TNF-α) or anti-inflammatory (IL-4 and
IL-10) cytokines. Accumulated literature suggests that IFN-γ can
act as a disease-protective or disease-inducing cytokine in various
myocarditis models, and such differential effects may be antigendependent (55). Likewise, IL-17A appears not to be required for
initiating the disease, but plays a critical role for progression of
myocarditis (56). We have also seen that cardiac-reactive T cells
produce mostly IFN-γ (30) and/or IL-17A in addition to IL-6 and
TNF-α in A/J mice (26, 28). Since, IFN-γ-production was found
to be unaltered with β1AR peptides, production of IL-17A alone
might be insufficient to initiate myocarditis which is consistent
with the observations made in Myhc 614–629-induced myocarditis (56). TNF-α and IL-6, being inflammatory cytokines may have
a role in myocarditis (57, 58), but their amounts were low in cultures stimulated with β1AR peptides to predict their impact. The
finding that IL-4 or IL-10 were detected in insignificant amounts
in all the cultures, suggests that the mild nature of disease in the

19–21-mers can act as common epitopes for both CD4 and CD8
T cells as shown with Myhc 334–352 (31), myelin oligodendrocyte glycoprotein 35–55 (52), and interphotoreceptor retinoidbinding protein 1–20 (53). In the present study however, we did
not investigate localization of CD8 T cell epitopes in the β1AR
peptides, and such an identity may then create opportunities to
determine how CD8 T cells independently or together with CD4
T cells can induce myocarditis, since their effector functions are
distinct (CD8 cytotoxic vs. CD4 Th).
Further, we made efforts to characterize CD4 T cell responses
as to their antigen-specificity. First, we determined MHC class
II-binding affinities of β1ARAc peptides using soluble MHC
class-II/IAk and IEk monomers (26, 28, 30). These analyses
revealed two of the three peptides that induced T cell responses
(Figure 1) namely, β1ARAc 171–190 and β1ARAc 211–230 could
bind IAk molecules as indicated by their respective IC50 values,
26.14 ± 12.41 and 18.64 ± 1.23 µM, whereas the binding affinity
of β1ARAc 181–200 was low (97.15 ± 2.07 µM) (Figure 3, left
panel; P < 0.01). Of note, in a comparative analysis, another peptide, β1ARAc 201–220 that did not induce T cell response failed
to bind IAk molecule (Figure S1B in Supplementary Material),
and it was not chosen for further characterization. Since, β1ARAc
181–200, a T cell activator was found to be a poor binder of
IAk, we generated IEk monomers to determine its ability to bind
IEk molecule, since A/J mice express both IAk and IEk molecules
(33, 34). By using IEk monomers, and MCC 82–103 as a reference
peptide, we determined that β1ARAc 181–200 to be a good binder
of IEk molecule as indicated by the IC50 value 6.12 ± 0.69 µM
(Figure 3, right panel). Based on this information, we decided
to create two sets of dextramers: IAk dextramers for β1ARAc
171–190 and β1ARAc 211–230 with RNase 43–56 as control, and
IEk dextramers for β1ARAc 181–200 and MCC 82–103 (control).
Using these reagents, we tested the antigen-specificity of T cell
responses in animals immunized with β1ARAc 171–190, β1ARAc
181–200, and β1ARAc 211–230, respectively. CD4 T cells from
cultures stimulated with the respective peptides were found to
bind dextramers antigen-specifically, whereas the staining intensity obtained with the control dextramers was low as determined

FIGURE 3 | Determination of major histocompatibility complex (MHC) class II-binding affinities of β1ARAc peptides. Mixtures containing thrombin-cleaved IAk and IEk
soluble monomers (0.35 µg), competitor peptides—β1ARAc 171–190, β1ARAc 181–200, and β1ARAc 211–230 (0.00001–100 µM)—and biotinylated hen egg lysozyme
(HEL) 46–61 (reference for IAk) and moth cytochrome c (MCC) 82–103 (reference for IEk) (1 µM) were prepared and added to fluorescence plates coated with anti-IAk
or IEk in duplicates as described in the methods. After washing, and addition of europium-labeled streptavidin (SA) and dissociation-enhanced lanthanide
fluoroimmunoassay (DELFIA) enhancer, fluorescence intensities were measured at excitation/emission wavelengths of 340/615 nm to calculate the IC50 values.
Mean ± SEM values from three individual experiments with two replicates in each are shown. **P < 0.01 and ***P < 0.001 vs. IC50 of IAk/β1ARAc 181–200.
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FIGURE 4 | Antigen-specificity of T cell responses induced by β1ARAc peptides. Lymph node cells (LNCs) or splenocytes prepared from animals immunized with
β1ARAc 171–190, β1ARAc 181–200, and β1ARAc 211–230 were restimulated with the corresponding peptides for 2 days and cells were rested in interleukin (IL)-2
medium. Cells harvested on days 7–10 poststimulation were stained with three sets of dextramers namely, IAk dextramers (β1ARAc 171–190 and RNase 43–56 as
control), panel (A); IEk dextramers [β1ARAc 181–200 and moth cytochrome c (MCC) 82–103 as control], panel (B); and IAk dextramers (β1ARAc 211–230 with RNase
43–56 as control), panel (C); followed by staining with anti-CD4 and 7-aminoactinomycin-D (7-AAD). Cells were acquired by flow cytometry, and the dext+ cells were
analyzed corresponding to CD4low or CD4high populations using Flow Jo software (bar graphs on the right side in each panel). Representative flow cytometric plots
are shown from two to three individual experiments, with two to five mice per group. *P < 0.05 and ***P < 0.001 vs. control dextramers.

immunized animals appear not due to immune deviation occurring toward Th2 phenotype.
To investigate whether β1AR-reactive cells producing differential amounts of Th1 and Th17 cytokines could determine the
disease outcome, we performed adoptive transfer experiments
using antigen-primed T cells treated with or without a cocktail
of cytokines that polarize toward Th1 and Th17 responses
(41–44). As shown in Figure S4 in Supplementary Material, we
noted increase in the frequencies of cells expressing Th1 (IL-2
and IFN-γ) and Th17 (IL-17A and IL-22) including Th2 (IL-4
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and IL-10) cytokines as reported by others (41–44, 59, 60).
However, comparative analysis revealed Th1-producing cells to
be significantly enhanced in β1AR 181–200 cultures as opposed
to Th2 cytokine-producing cells in β1ARAc 171–190 and β1ARAc
211–230 cultures but with no significant increase in the Th17
subset in any of the groups. Table 2 shows that the naive
animals receiving unpolarized lymphocytes specific to β1ARAc
171–190 and β1ARAc 211–230 had no inflammatory foci in their
hearts, where as one animal receiving β1ARAc 181–200-primed
lymphocytes had heart lesions. When the cells were exposed
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FIGURE 5 | Cytokine responses induced by β1ARAc peptides. Lymph node cells (LNCs) were prepared from animals immunized with acetylated or non-acetylated
β1AR 171–190, β1AR 181–200, or β1AR 211–230, and after restimulating with or without the immunizing peptides or RNase 43–56/HEL 46–61 (negative controls),
culture supernatants were harvested on day 3. Samples were analyzed for indicated cytokines by bead array analysis as described in the methods section. Each bar
represents mean ± SEM values derived from four to five individual experiments, with three to eight mice per group.

to the polarizing conditions as described above, it was clear
that the naive animals receiving β1ARAc 181–200-primed
lymphocytes had severe myocarditis (25.8 ± 7.4 foci; Table 2;
Figure 6A; Figure S5 in Supplementary material). Under similar
conditions, β1ARAc 171–190-and β1ARAc 211–230-responsive
Frontiers in Immunology | www.frontiersin.org

lymphocytes did not result in disease, which may be due to their
enhanced ability to produce Th2 cytokines (Table 2; Figure S4
in Supplementary Material). Expectedly, heart sections from
control groups (saline and LPS/PT) also were negative for
inflammatory changes (Table 2; Figure 6A). Furthermore, by
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sources for isotype switching to occur. One potential source is
the adjuvant (CFA) that can promote isotype switching through
the secretion of Type I IFNs from dendritic cells as shown previously (61). Furthermore, it is to be noted that β1ARAc 201–220
encompasses 20 amino acids of the previously reported B cell
epitope, β1AR 197–222 that was shown to induce antibodies
in various rodent species (21, 24, 25). Our data also supports
this observation. Detection of antibodies to β1ARAc 191–210
may be due to the presence of overlapping sequence between
β1ARAc 191–210 and β1ARAc 201–220. However, the observation
that β1ARAc 201–220 failed to induce myocarditis in our model
may not necessarily mean that the β1ARAc 201–220-induced
antibodies are not pathogenic. The reason for this discrepancy
is that animals needed to be repeatedly immunized with β1ARAc
197–222 for a period of 12 months in rats and rabbits, and
mice were also to be immunized with six doses of CFA/peptide
emulsions (21–25). We did not investigate whether A/J mice
immunized for such a prolonged period can develop myocarditis, since we limited our focus to the extent of identifying T cell
epitopes, and their ability to induce myocarditis in a standard
disease-inducing protocol.
In summary, we demonstrate existence of multiple immunodominant epitopes that are unique to T cells or B cells, but not
both. Use of a single motif, β1AR 197–222 as a B cell epitope
to determine the mechanisms of antibody-mediated myocardial
disease in several rodent species was perhaps on the idea that
the epitope was found conserved (Table S1 in Supplementary
Material). Along the same lines, comparison of sequences
between humans, mice, rats and rabbits revealed 100% identity for
all T cell epitopes that we have described namely, β1AR 181–200,
and β1AR 211–230 with only one residue being different for β1AR
171–190 between humans and mice (Table S6 in Supplementary
Material), suggest that these epitopes may be relevant to evaluate
T cell responses in humans. In addition, we noted that splenocytes from naive animals responded to two out of three T cell
epitopes namely, β1ARAc 171–190, and β1ARAc 181–200 (Figure
S6 in Supplementary Material) indicating that the naive repertoire can contain a proportion of β1AR-reactive T cells that might
have responded in response to peptide immunizations. Reports
suggest that β1AR proteins are differentially expressed in the
thymus with a predominant form being β2AR (62). It is possible
that the developing thymocytes may escape from thymic tolerance mechanisms due to low β1AR-expression in the thymus
leading to their emigration to the periphery. Thus, we speculate
that the preexisting β1AR-reactive T cells can be activated under
conditions of self-tolerance to be broken by environmental triggers. Of note, cross-reactive immune responses have been noted
between Trypanosoma cruzi and β1AR and it might be interesting to determine whether such responses are directed against the
T cell epitopes in A/J mice which are also highly susceptible to
T. cruzi infection (63, 64). Additionally, we have demonstrated
that the β1AR-reactive T cells producing insufficient amounts of
IFN-γ can become pathogenic under Th1-polarized conditions.
Thus, we could envision a scenario that IL-12 produced by the
innate immune cells such as macrophages and dendritic cells
in response to intracellular pathogens like T. cruzi can possibly trigger IFN-γ-producing β1AR-reactive T cells to become

TABLE 2 | Myocarditis induced by T cells sensitized with β1ARAc peptides in
naive A/J mice.
Groups

Incidence (%)

Inflammatory focia

Saline
LPS/PT

0/4 (0)
0/4 (0)

0
0

Unpolarized cells
β1ARAc 171–190
β1ARAc 181–200
β1ARAc 211–230

0/4 (0)
1/4 (25)
0/4 (0)

0
6
0

Th1- and Th17-polarized cells
0/4 (0)
β1ARAc 171–190
β1ARAc 181–200
4/4 (100)*
β1ARAc 211–230
1/4 (25)

0
25.8 ± 7.4**
1

a
Represents mean ± SEM values derived from myocarditic animals.
*P < 0.05 vs. control groups.
**P < 0.01 vs. control groups.

IHC analysis, we noted detection of CD3+, CD4+ and CD8+
T cells and also CD11b+ macrophages in heart sections from
animals that received β1ARAc 181–200-primed/polarized lymphocytes (Figure 6B). These findings may reinforce the notion
that the disease induced with β1ARAc peptides represents a
T cell-mediated, disease as we have demonstrated with other
antigens namely, Myhc, ANT, and BCKD kinase (26, 28, 30).
While, cytokine-polarized experiments provided explanations
as to why the disease-severity was mild in animals that received
CFA/β1ARAc peptide emulsions by active immunizations, occurrence of disease with only β1ARAc 181–200-sensitized T cells,
but not for two other peptides (β1ARAc 171–190 and β1ARAc
211–230) in adoptive transfer experiments may indicate that
both Th1 and Th17 cytokines are critical for disease induction.
Alternatively, it is possible that cytokines other than Th1 and
Th17 subsets may have a role in the disease-mediation with
β1ARAc 181–200-sensitized T cells because comparison of frequencies of cytokine-producing cells between groups did not
reveal striking differences for any of the cytokines tested.
Finally, we evaluated antibody responses for a panel of
β1ARAc peptides. These include peptides that induced both T cell
responses and disease (β1ARAc 171–190, β1ARAc 181–200, and
β1ARAc 211–230), and those that did not induce T cell responses
or disease (β1ARAc 191–210 and β1ARAc 201–220). Serum
samples collected from immunized animals were tested for
their reactivity to the immunizing peptides as indicated above
or an irrelevant control, RNase 43–56. The analyses revealed
detection of total Igs specific to β1ARAc peptides, since such
a reactivity was found lacking for RNase 43–56 (Figure 7A).
However, comparison of antibody responses between different
peptides revealed antibody response to β1ARAc 201–220 and to
some degree, β1ARAc 191–210 (Figure 7A). By further characterizing various isotypes, we noted that the antibody response
induced with β1ARAc 201–220 involved the production of all
IgG isotypes (IgG1, IgG2a, IgG2b, IgG3) including IgM, except
IgA and IgE (Figure 7B). By being a non-T cell activator (Figure
S1A in Supplementary Material), production of various isotypes
of Abs specific to β1ARAc 201–220 may mean that the antigenspecific B cells might have received cytokines from non-T cell
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FIGURE 6 | Evaluation of hearts for inflammatory changes in naive recipients of T cells sensitized with β1ARAc 181–200. (A) Hematoxylin and eosin (H&E) staining.
Groups of mice were immunized with a mixture of β1ARAc 171–190, β1ARAc 181–200, and β1ARAc 211–230 and after 14–21 days, lymph node cells (LNCs) were
restimulated with the corresponding peptides for 2 days. After exposing to T helper (Th)1- and Th17-polarizing conditions, cells harvested on day 7 postpolarization
and administered into naive mice primed with lipopolysaccharide (LPS). Representative normal heart sections in saline and LPS/PT controls are shown in the top panel.
The bottom panel represents recipients of β1ARAc 181–200-sensitized/polarized T cells. Circled areas are shown at higher magnifications to the right in each panel
(arrows, inflammatory foci). Scale bar: 120 µm (overview images, 10×), 30 µm (magnifications, 40×). n = 4 mice per group. (B) Immunohistochemistry. Heart sections
were examined for T cells and non-T cells using the antibodies for indicated markers. Detection of cells positive for each marker (arrows) was analyzed by adding
HRP-conjugated secondary antibodies as described in the methods section. Representative sections from four animals in each group are shown. Scale bar, 60 µm.
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FIGURE 7 | Antibody responses induced by β1ARAc peptides. Groups of mice were immunized with β1ARAc 171–190, β1ARAc 181–200, β1ARAc 191–210, β1ARAc
201–220, or β1ARAc 211–230 and after 21 days, serum was collected. Samples with dilutions of 1:100 were added to low-binding plates coated previously with
or without the above peptides or RNase 43–56 (control). After adding horseradish peroxidase (HRP)-conjugated, goat anti-mouse detection antibodies for Igs and
different isotypes, plates were read at 405 nm to measure the OD values. Each bar represents mean ± SEM values derived from five animals per group. **P < 0.01
vs. controls. (A) Total immunoglobulins and (B) antibody isotypes.
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